As on Wednesday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) got off with the flyer as it spiked 1.61% to $15.17, before settling in for the price of $14.93 at the close. Taking a more long-term approach, PHAT posted a 52-week range of $2.21-$16.08.
It was noted that the giant of the Healthcare sector posted annual sales growth of 12.50% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 12.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.34%. This publicly-traded company’s shares outstanding now amounts to $71.04 million, simultaneously with a float of $41.32 million. The organization now has a market capitalization sitting at $1.08 billion. At the time of writing, stock’s 50-day Moving Average stood at $13.13, while the 200-day Moving Average is $8.71.
Phathom Pharmaceuticals Inc (PHAT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Phathom Pharmaceuticals Inc’s current insider ownership accounts for 41.92%, in contrast to 50.73% institutional ownership. According to the most recent insider trade that took place on Nov 03 ’25, this organization’s Principal Accounting Officer sold 524 shares at the rate of 13.51, making the entire transaction reach 7,079 in total value, affecting insider ownership by 47,407. Preceding that transaction, on Sep 05 ’25, Company’s Principal Accounting Officer sold 461 for 12.09, making the whole transaction’s value amount to 5,573. This particular insider is now the holder of 47,931 in total.
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Trading Performance Indicators
Let’s observe the current performance indicators for Phathom Pharmaceuticals Inc (PHAT). It’s Quick Ratio in the last reported quarter now stands at 2.19. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 7.33.
In the same vein, PHAT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.81, a figure that is expected to reach -0.42 in the next quarter, and analysts are predicting that it will be -0.73 at the market close of one year from today.
Technical Analysis of Phathom Pharmaceuticals Inc (PHAT)
Through scrutinizing the latest numbers posted by the [Phathom Pharmaceuticals Inc, PHAT], it can be observed that its last 5-days Average volume of 0.71 million was lower the volume of 1.57 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 69.95% While, its Average True Range was 65.03.
Raw Stochastic average of Phathom Pharmaceuticals Inc (PHAT) in the period of the previous 100 days is set at 89.26%, which indicates a major fall in contrast to 92.26% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.82 that was higher than 0.80 volatility it exhibited in the past 100-days period.
